Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but its shares ...

The Global Findex Database is the world's only demand-side survey on financial inclusion and a leading source of data on how adults around the world access and use financial services. Since its launch ...